Invesco Dynamic Pharmaceuticals ETF (PJP) Shares Sold by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC lowered its stake in shares of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) by 39.0% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 19,491 shares of the company’s stock after selling 12,481 shares during the period. Tower Research Capital LLC TRC’s holdings in Invesco Dynamic Pharmaceuticals ETF were worth $1,310,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of PJP. Citadel Advisors LLC lifted its stake in shares of Invesco Dynamic Pharmaceuticals ETF by 35.5% in the 2nd quarter. Citadel Advisors LLC now owns 41,549 shares of the company’s stock worth $2,793,000 after purchasing an additional 10,882 shares during the period. Madison Investment Holdings Inc. lifted its stake in shares of Invesco Dynamic Pharmaceuticals ETF by 26.6% in the 2nd quarter. Madison Investment Holdings Inc. now owns 41,069 shares of the company’s stock worth $2,760,000 after purchasing an additional 8,627 shares during the period. Kiley Juergens Wealth Management LLC bought a new position in shares of Invesco Dynamic Pharmaceuticals ETF in the 2nd quarter worth approximately $112,000. Cornerstone Wealth Management LLC bought a new position in shares of Invesco Dynamic Pharmaceuticals ETF in the 2nd quarter worth approximately $934,000. Finally, Reilly Financial Advisors LLC bought a new position in shares of Invesco Dynamic Pharmaceuticals ETF in the 2nd quarter worth approximately $1,844,000.

Shares of NYSEARCA:PJP opened at $72.19 on Friday. Invesco Dynamic Pharmaceuticals ETF has a twelve month low of $59.82 and a twelve month high of $74.29.

About Invesco Dynamic Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.

Featured Story: Hedge Funds – Risk or Reward?

Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP).

Institutional Ownership by Quarter for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

Receive News & Ratings for Invesco Dynamic Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply